Biotechnology ResearchCalifornia, United States201-500 Employees
Mirati Therapeutics, Inc. is now part of Bristol Myers Squibb. Follow our progress delivering breakthrough therapies that target the genetic drivers of cancer @Bristol Myers Squibb or www.bms.com
| Mirati Therapeutics Email Formats | Percentage |
| LastF@mirati.com | 88% |
| FLast@mirati.com | 5% |
| Last@mirati.com | 4% |
| First@mirati.com | 1% |
| FirstL@mirati.com | 1% |
| LastFir@mirati.com | 1% |
| First.Last@bms.com | 94% |
| LastF@bms.com | 3% |
| Last.First@bms.com | 2% |
| First.Middle@bms.com | 1% |
Check if your email matches the formats in our database with our efficient email format checker tool.
| Matching Format | Percentage |
| LastF@mirati.com | 88% |
| FLast@mirati.com | 5% |
| Last@mirati.com | 4% |
| First@mirati.com | 1% |
| FirstL@mirati.com | 1% |
| LastFir@mirati.com | 1% |
| First.Last@bms.com | 94% |
| LastF@bms.com | 3% |
| Last.First@bms.com | 2% |
| First.Middle@bms.com | 1% |
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com